The human immunodeficiency virus type 1 (HIV-1) is a primate lentivirus that causes the acquired immunodeficiency syndrome (AIDS). In addition to the virion structural proteins and enzyme precursors, that are Gag, Env and Pol, HIV-1 encodes several regulatory proteins, notably a small nuclear transcriptional activator named Tat. The Tat protein is absolutely required for virus replication since it controls proviral DNA transcription to generate the full-length viral mRNA. Tat can also regulate mRNA capping and splicing and was recently found to interfere with the cellular mi-and siRNA machinery. Because of its extensive interplay with nucleic acids, and its basic and disordered nature we speculated that Tat had nucleic acid-chaperoning properties. This prompted us to examine in vitro the nucleic acid-chaperoning activities of Tat and Tat peptides made by chemical synthesis. Here we report that Tat has potent nucleic acid-chaperoning activities according to the standard DNA annealing, DNA and RNA strand exchange, RNA ribozyme cleavage and trans-splicing assays. The active Tat(44-61) peptide identified here corresponds to the smallest known sequence with DNA/RNA chaperoning properties.
INTRODUCTION
The human immunodeficiency virus type 1, HIV-1, is a member of the lentivirus family that is widespread in primates, and is the causative agent of the acquired immunodeficiency syndrome known as AIDS (1) . HIV-1 codes for the three canonical retroviral polyprotein precursors, which are needed for virus formation and infectivity, namely Gag, Pol and Env (2) . As a complex retrovirus, HIV-1 also encodes six regulatory proteins, namely Tat, Rev, Vpr, Vpu, Vif and Nef, that carry out important roles in virus replication, either acting at the level of viral RNA synthesis and its nuclear export in the case of Tat and Rev, or suppressing virus restriction by the host factor APOBEC 3G in the case of Vif (3, 4) . At the end of the early steps of HIV-1 replication, the newly made proviral DNA is integrated into the host genome via the concerted action of the viral integrase enzyme, the nucleocapsid (NC) protein, and the cellular cofactor LEDGF (5) (6) (7) . In infected cells, transcription of the integrated proviral DNA requires the viral Tat protein for the synthesis of the full-length viral mRNA. As extensively documented, Tat is a small nuclear transcriptional activator which controls productive proviral DNA transcription from the 5 0 long terminal repeat (LTR) of HIV-1, via its interaction with the transactivation response (TAR) RNA element (2, 8, 9) . As for any transcriptional activator, Tat could facilitate either of two reactions taking place at the beginning of DNA transcription, namely recruitment of an RNA polymerase II (RNAP II) complex to the promoter, and the escape of that initial complex from the promoter into productive RNA synthesis (8, 10, 11) . In fact, the most likely scenario by which Tat activates by several 100-fold transcription from the HIV-1 5 0 LTR, is that Tat promotes an efficient transcription elongation. The conversion of non-processive RNAP II complexes into productive ones by Tat has been the matter of a large number of studies, which led to the identification of many Tat-associated host transcription factors and regulatory proteins (12) (13) (14) (15) . A highly simplified view proposes that Tat contacts the nascent viral TAR RNA and recruits various transcription factors such as the TATA-binding protein (TBP), the general transcription factor TFIIB and the positive transcription elongation factor B (P-TEFB), itself composed of cyclin T1 and the cyclin-dependent kinase 9 (CDK9). This leads to the formation of very active elongating transcription complexes (16, 17) . The hyperphosphorylation of RNAP II by CDK9 will also ensure the rapid cyclic reuse of elongation complexes to achieve a continuous and rapid reinitiation of transcription to the benefit of the viral promoter strength (18, 19) . This scenario favors the notion that Tat acts by interacting with multiple viral and cellular partners at a time. In accordance with the view that Tat is multi-functional it has been shown that Tat also regulates mRNA capping (20) and splicing (21) , and interferes with the cellular RNA interference (RNAi) machinery through interactions with DICER and RNA (22, 23) .
Tat is a small basic protein conserved in all primate lentiviruses (24) , and is poorly structured as a free protein in solution (25) . The basic and intrinsically disordered nature of the HIV-1 Tat protein may well account for its ability to interact with several proteins and nucleic acids in a manner similar to RNA chaperones such as the HIV-1 NC protein, Flaviviridae core proteins, or the cellular fragile X mental retardation protein FMRP (26) (27) (28) . These unique features of Tat made us speculate that it had general nucleic acid-chaperoning activities resembling those of HIV-1 NCp7, as suggested by recent publications (29, 30) . To examine this possibility, Tat and Tat peptides were synthesized and their nucleic acid-chaperoning activities were extensively studied in vitro. Here we show that Tat has potent nucleic acid-chaperoning activities, as evidenced by a number of standard RNA chaperoning assays (RCA) (31, 32) . We also find that the basic Tat (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) peptide encompassing the Tat basic domain is the smallest reported peptide with nucleic acid-chaperone activities.
MATERIALS AND METHODS

DNA substrates
The HIV-1 LTR DNA corresponding to the NY5 strain was generated by PCR, 5 0 end 32 P-labelled and purified by electrophoresis on a 1% agarose gel followed by QIAEX II extraction (Qiagen).
Oligodeoxynucleotides (ODNs) used for DNA binding, annealing and strand transfer assays corresponded to the HIV-1 TAR and the repeated R sequences, in the sense and anti-sense orientations, respectively. ODNs used for the HIV-1 RNA displacement assays (ÁU3-R), in the sense or anti-sense orientation, corresponded to part of the LTR. ODNs were purchased from Eurogentec (Belgium) and IBA GmbH Nucleic Acids Product Supply (Go¨ttingen, Germany). TAR, R and ÁU3-R ODNs are 56, 96 and 74 nt in length, respectively. ODNS ÁU3-R(+) and (-) were used to mimic the start of transcription and release of the nascent RNA.
TAR(À), R(+) and ÁU3-R(À) ODNs were 32 P-labelled with 50 mCi of [a-32 P]ATP using T4 polynucleotide kinase. 32 P-labelled ODNs were purified by 10% PAGE, 7 M urea in 50 mM Tris-borate, 1 mM EDTA, pH 8.3 (0.5Â TBE). They were recovered, ethanol precipitated and dissolved in sterile H 2 O before use.
Fluorescently labelled TAR(À) derivatives were labelled at their 3 0 termini with 5(and6)-carboxyfluorescein (Fl) using a special solid support with the dye already attached. In doubly labelled TAR(À) derivatives, the 5 0 end was additionally labelled with carboxytetramethylrhodamine (TMR) via an amino-linker with a six carbon spacer arm. Labelled oligonucleotides were purified by reverse-phase HPLC and polyacrylamide gel electrophoresis.
In vitro generated RNAs
RNAs used for the ribozyme assay were synthesized by in vitro transcription with T7 RNA polymerase as previously published (31 
Tat and NC proteins
Biologically active full-length Tat protein and Tat peptides were chemically synthesized using optimized Fmoc chemistry protocols, and were purified by reverse-phase HPLC (34) . Their purity was monitored by analytical RP-HPLC on a Beckman instrument (Gagny, France) with a Nucleosil C18 5-mm column (150 Â 4.6 mm) and a Nucleosil C4 5-mm column (150 Â 4.6 mm), respectively, using a linear gradient of 0.1% TFA in water and acetonitrile containing 0.08% TFA at a flow rate of 1.2 ml/min. Finally, integrity of each peptide was assessed by matrix-assisted laser desorption and ionization time-offlight spectrometry on a Protein TOF TM mass spectrometer (Bruker, Wissembourg, France). The mass of Tat protein was assessed by LC/MS using a Thermofinigan LCQ. NCp7 and mutant NCp7 were chemically synthesized and purified by RP-HPLC as previously published (29, 35) . Peptides were dissolved at 1 mg/ml in a freshly prepared oxygen-free buffer containing 30 mM HEPES pH 6.5, 30 mM NaCl and 0. 
UV-visible absorption and steady-state fluorescence measurements
Absorption spectra were recorded on a Cary 400 spectrophotometer. Fluorescence emission spectra and kinetic traces were recorded on a FluoroMax spectrofluorometer (Jobin Yvon) equipped with a thermostated cell compartment. Binding experiments were performed by adding increasing peptide concentrations to 10 nM TAR(À)-3 0 -Fl and monitoring the steady-state fluorescence anisotropy using a T-format SLM 8000 spectrofluorometer at 208C. The emitted light of TAR(À)-3 0 -Fl was monitored through high-pass filters (520 nm) (Kodak). A home-built device ensured the automatic rotation of the excitation polarizer. The apparent binding constant K app was recovered by fitting the fluorescence anisotropy data using:
where S 0 and S t are the initial and the final anisotropy, respectively; n À number of binding sites; and P t , N t concentrations of protein and oligonucleotide, respectively. traces were adequately fitted with a bi-exponential function:
where t 0 is the dead time, k obs1,2 are the observed kinetic rate constants, x is the amplitude of the fast component, and I 0 and I f are the fluorescence intensities of the stemloop and extended duplex structures, respectively. All fitting procedures were carried out with the Microcal Origin 6.1 software based on the nonlinear, least-squares method and the Levenberg-Marquardt algorithm.
Electrophoresis-based nucleic acid binding and chaperoning assays
The DNA-binding assay. The 32 P-labelled TAR(À) DNA (0.03 pmol) was incubated with an increasing concentration of Tat or Tat peptide for 5 min at 378C in buffer A (20 mM Tris-HCl pH 7.0, 30 mM NaCl, 0.1 mM MgCl 2 , 5 mM DTT and 10 mM ZnCl 2 ). Next, we added 5 ml of a solution containing 20% glycerol, 20 mM EDTA pH 8.0 and 0.25% bromophenol blue. Nucleoprotein complexes were analysed by 1% agarose gel electrophoresis in stringent conditions (0.5Â TB pH 8.3, 1 mM EDTA at 208C). The agarose gel was dried and then submitted to autoradiography.
The TAR(À)/TAR(+) DNA annealing assay. TAR(+) and 32 P-TAR(À) ODNs were incubated (0.03 pmol each) in 10 ml of buffer A at increasing protein concentrations as indicated in the figure legends. Reactions were performed at 378C for 5 min except for the positive control that was incubated at 658C. To stop the reaction and denature the protein in order to release it from the 32 P-ODN, we added 5 ml of a solution containing 20% glycerol, 20 mM EDTA pH 8.0, 2% SDS, 0.25% bromophenol blue and 0.4 mg/ml calf liver tRNA. Samples were resolved by 8% native PAGE in 50 mM Tris-borate pH 8.3, 1 mM EDTA at 48C. Subsequently, gels were autoradiographed and the amounts of labelled single-stranded and double-stranded DNA were assessed by phosphorimaging.
The DNA strand exchange assay.
P-labelled R(+) wt, R(À).3
0 -modified and R(À) wt were separately heat denatured for 2 min at 958C and chilled on ice. All components were kept at 48C. 0.03 pmol each of 32 
P-labelled R(+) wt and R(À).3
0 -modified, at a concentration of 6 Â 10 À8 M, were mixed with the reaction buffer to a final concentration of 20 mM Tris-HCl, pH 7.0, 30 mM NaCl, 0.1 mM MgCl 2 , 10 mM ZnCl 2 and 5 mM DTT in 5 ml final volume, incubated for 30 min at 628C under oil and chilled on ice. Then, 0.03 pmol of R(À) wt was added together with the protein using a protein to nucleotide molar ratio as indicated in the figure legends. Assays were conducted for 5 min at 378C, then chilled on ice and stopped with 2.5 ml of 20% glycerol, 20 mM EDTA pH 8.0, 0.2% SDS, 0.25% bromophenol blue and 0.4 mg/ml calf liver tRNA. Samples were resolved by 6% native PAGE in 0.5Â TBE at 48C and gels were subsequently autoradiographed. Levels of DNA strand exchange were assessed by phosphorimaging.
The hammerhead ribozyme cleavage assay. Ribozyme and substrate RNA were independently heated for 1 min at 908C in sterile H 2 O. The reaction buffer was added to yield final concentrations of 5 mM MgCl 2 , 100 mM NaCl, 20 mM Tris-HCl, pH 7.5. After slow cooling to 378C, RNAs were incubated for 5 min at 208C. Ribozyme measuring 0.02 pmol and 0.08 pmol of RNA substrate were then combined in a final volume of 10 ml. Each protein was added at final protein to nucleotide molar ratios as indicated in the legend of the figures. Incubations were for 20-30 min at 378C. Reactions were stopped by adding 20 ml of the stop solution (0.3% SDS, 15 mM EDTA), and extracted with 30 ml of phenol and 15 ml of chloroform. The aqueous phase was precipitated with ethanol and the pellet re-suspended in 45% formamide, 0.5Â TBE and 0.1% dyes.
32 P-labelled RNAs were analysed on 8% PAGE in 7 M urea and 0.5Â TBE. After electrophoresis, gels were autoradiographed and levels of RNA cleavage were assessed by phosphorimaging.
The RNA trans-splicing assay. In vitro generated RNAs (0.2 pmol of each 35 S-labelled RNA) (2 Â 10 À8 M) were incubated for 1 min at 958C in sterile H 2 O. After slow cooling down to 378C, the splicing buffer (40 mM TrisHCl at pH 7.4, 3 mM MgCl 2 , 0.4 mM spermidine, 4 mM DTT), 8 U RNasin and 0.33 pmol 32 P-GTP were added. Protein was added to final protein to RNA molar ratios as indicated in the figure legends (typically at concentrations of 2 Â 10 À8 to 10 À7 M). Incubation was for 30 min at 378C in 10 ml final volume. Reactions were stopped by adding a stop solution (40 mM EDTA, 5 mg of tRNA). Proteins were removed by phenol-chloroform extractions, and samples processed as above. Precipitated RNAs were re-suspended in 85% formamide, 0.5Â TBE and 0.1% dyes (xylene cyanol and bromophenol blue), heat denatured and loaded on a denaturing 5% PAGE in 7 M urea and 0.5Â TBE. 5 0 32 P-labelled FX174 DNA HinfI markers (Promega) were used for size determination (not shown). After electrophoresis, gels were autoradiographed and levels of trans-splicing were assessed by phosphorimaging.
The DNA/RNA exchange assay. The ODN ÁU3-R(À) and viral 32 P-RNA (nt 1-46) (0.1 pmol each) were heat denatured for 2 min at 908C and annealed at 608C for 30 min in buffer A, in 10 ml final volume. Then, ODN ÁU3-R(+) (0.1 pmol) was added together with Tat or Tat peptide, followed by incubation for 5 min at 308C. Reactions were stopped and proteins removed as indicated above. ODNs and RNA were separated on a 400 Spreadex gel under native conditions (Euromedex). Quantitations were by phosphorimaging as above.
RESULTS
Binding of Tat and Tat peptides to TAR DNA
The HIV-1 transactivator Tat is a basic protein of about 11.5 kDa, which tightly binds a short nascent stem-loop RNA structure, TAR (transactivation response element), for its activity (37, 38) . Tat is encoded by two exons, namely exon 1 for residues 1 to 72 and exon 2 for residues 73-86 in the case of laboratory strains and 73-101 found in most clinical isolates (39) . Tat contains five domains that are the N-terminal domain I (aa [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , the cysteinerich domain II (aa [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , the hydrophobic core domain III (aa [41] [42] [43] [44] [45] [46] [47] [48] , the RNA-binding domain IV encompassing the basic RKKRRQRRR motif and a glutamine-rich region (aa 49-72) necessary for the transactivation, and the C-terminal domain V of variable size (73-86 or 73-101) (Figure 1 ). Tat contains a large number of conserved arginine and lysine residues, notably between positions 45 and 60 in the core and RNA-binding domains. In good agreement with recently published NMR data (25) , a computer prediction of Tat folding indicated that Tat alone is mostly unstructured (Supplementary Figure 1) , and thus could be classified as an intrinsically unstructured protein (IUP), a hallmark of cellular and viral RNA chaperones (28, 40) . In order to examine the nucleic acid binding and potential chaperoning properties of Tat, full-length Tat (1-86) and Tat peptides corresponding to the N-terminal domain I (aa [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , to the cysteine-rich domain (aa , to part of the core and RNA-binding domains III/IV (aa [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] and to the glutamine-rich region together with the C-terminus (aa 48-86) were synthesized and purified to homogeneity in conditions preventing oxidation in vitro (see Materials and methods section).
Tat and the peptides were examined for their ability to bind nucleic acids in vitro, using TAR DNA at a concentration of 3 Â 10 À9 M and stringent conditions (see Materials and methods section). As shown in Figure 2A For Tat , the number of binding sites was found to be about seven (Table 1) Tat (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) , this explains the higher anisotropy plateau observed with the former peptide. No DNA binding was observed for Tat (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . The apparent binding constant, K app , was determined for the peptides (Figure 2B ), by assuming that the binding sites on TAR DNA are identical and independent. This approach was shown to be reasonable to assess the affinities of other viral proteins and their mutants to TAR DNA (41, 42) . By fitting the binding curves with Equation (1) The basic and intrinsically unstructured nature of Tat, together with its ability to strongly bind nucleic acids suggested to us that Tat could have nucleic acidchaperoning properties, similar to the NC protein of HIV-1, that is a key viral factor involved in proviral DNA synthesis (5, 6, 29, 43) . To investigate how Tat may assist nucleic acid folding, we used standard nucleic acid chaperone assays, namely DNA annealing and strand exchange (44), ribozyme-directed cleavage of an RNA substrate (45) and RNA trans-splicing (32,33,46).
Tat stimulates DNA annealing and strand exchange
The DNA annealing assays used the TAR(+) and TAR(À) sequences of 56 nt in length, which fold into stable stem-loop structures. Hybridization of TAR(+) to TAR(À) to form a double-stranded DNA was examined by PAGE in native conditions ( Figure 3A) . The number of binding sites, n, and the apparent binding constant, K app , were determined as described in Figure 2 .
c The occluded binding size was calculated by dividing the number of TAR(À) nucleotides by n. (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) at the same ratio and is thus not represented. Excitation and emission wavelength were 480 nm and 520 nm, respectively. The lines correspond to the fit of the kinetic traces with Equation (2) and the parameters of To quantify the Tat-promoted TAR(+)/TAR(À) annealing, we monitored their real-time annealing kinetics in pseudo-first-order conditions by mixing 10 nM TMR-5 0 -TAR(À)-3 0 -Fl with a 30-fold excess of non-labelled TAR(+). Formation of the TAR(+)/TAR(À) extended duplex (ED) strongly increases the interchromophore distance, leading to a full recovery of Fl emission (47) . In the absence of Tat, TAR(+)/TAR(À) DNA annealing was previously shown to involve two distinct kinetic components characterized by two slow second-order rate constants (48) . Due to the high concentration of TAR(+) needed for the pseudo-first-order conditions, distorted kinetic traces owing to aggregation were observed when Tat(1-86) was added at a molar ratio of protein to TAR ! 2 or when Tat(48-86) or Tat (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) was added at a ratio of protein to TAR ! 5. As a consequence, the annealing reactions were monitored at lower ratios where no aggregation occured. In the presence of Tat(48-86) or Tat (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) at a molar ratio of three peptide molecules per TAR, the same fluorescence plateau was reached as with the Tat protein, indicating that the reaction went to completion generating the ED ( Figure 3C ). Tat and the two peptides dramatically increased the annealing kinetics, since the reaction was complete in <10 min, instead of more than one day in the absence of Tat peptide. The observed kinetic rate constants (k obs1 and k obs2 values) with the two peptides were respectively one and two orders of magnitude larger than the corresponding values in the absence of peptide ( Table 2 ). The similar annealing activities of the two peptides suggested that these activities are mainly supported by the nucleic acid-binding (aa [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] domain. In agreement with this, monitoring of the Tat annealing activity by fluorescence intensity showed that it was about 10 times less active than Tat(44-61) ( Table 2 ). Comparison of Tat (44-61) with Tat(1-86) at a molar ratio of one peptide per TAR further revealed that the full-length Tat was substantially more active than the peptide (Table 2 ). This indicates that residues flanking the basic (48-61) domain contribute to the Tat-promoted TAR(+)/TAR(À) annealing and that a substantial promotion of TAR(+)/TAR(À) annealing can be achieved at a molar ratio as low as one Tat per TAR sequence. In sharp contrast, no promotion of TAR(+)/ TAR(À) DNA annealing was observed with Tat(1-20) ( Figure 3C and Table 2 ).
The next assays aimed at investigating the ability of Tat to promote formation of the most stable double stranded nucleic acid. These assays used three DNA molecules of 96 nt in length representing the R sequence of the HIV-1 LTR ( Figure 4A ). First, R(+) was annealed to a mutant R(À) containing seven mutations at its 3 0 end Experimental conditions were as described in Table 1 . The k obs values were obtained by fitting the kinetic traces in Figure 2 by Equation 2. (Materials and methods section) by heating at 628C for 30 min ( Figure 4B , lane 3 to be compared with lane 2 corresponding to the R(+):R(À) DNA). Next, R(À) DNA and Tat were added to the imperfect doublestranded DNA and incubated for 5 min at 378C ( Figure 4A ). The final DNA products were analysed by PAGE in native conditions. As previously reported, HIV-1 NCp7 directed DNA strand exchange by replacing the mutated R(À) by the wild type R(À) in the double stranded DNA (data not shown and refs 5, 6, 43) . The basic peptide NC(12-53) was able to bind DNA but unable to promote the DNA strand exchange under these in vitro conditions (data not shown). Tat was efficient at directing the DNA strand exchange ( Figure 4B, lanes 5-7) at concentrations of 1-2 Â 10 À7 M. Tat peptides (44-61) (lanes 11-15) and (48-86) (lanes 16-20) also promoted strand exchange at concentrations of 1-2 Â 10 À7 M. Again, Tat(44-61) was clearly more active than Tat(48-86) (compare lanes 12 and 17) while Tat (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) was inactive even at 10 À6 M (lanes 8-10).
Tat enhances hammerhead ribozyme cleavage of an RNA substrate
Ribozyme-directed cleavage of an RNA substrate allows examination of both the RNA annealing and unwinding activities of nucleic acid chaperones (31) . Chaperones are thought to enhance the rate of ribozyme cleavage by activating the annealing of the substrate RNA to the ribozyme ( Figure 5A , step 1) and the unwinding and release of the RNA products ( Figure 5A , step 3), thus allowing fast recycling of the ribozyme. The ribozyme cleavage assay examines whether Tat can accelerate ribozyme cleavage of an RNA substrate in a manner similar to the viral NCp7 chaperone (see Figure 5A ) (31, 49) . We selected the R3 hammerhead ribozyme and two RNA substrates, namely S14 with a 14-nt substrateribozyme duplex length (7 nt on either side of the cleavage site) and S20 with 10 nt on either side of the cleavage site.
The above RNA substrate model system was chosen due to its likely biological relevance as evidenced by the similarity of data obtained in vitro and in cultured cells (49) . Labelled RNA S14 ( Figure 5B, lane 1) , the ribozyme R3 (lane 2) and Tat or a Tat peptide were mixed and incubated. Next, RNAs were deproteinized, recovered and analysed by PAGE under denaturing conditions. In the absence of a chaperone, ribozyme-directed cleavage of the RNA substrate occurred only slowly at 378C ( Figure 5B , lanes 3 at 48C and 4 at 378C; labelled RNA substrate is S14 and cleaved product ÁS14). In agreement with previous reports (49), HIV-1 NCp7 caused ribozyme cleavage of RNA S14 to reach completion at a concentration as low as 2 Â 10 À8 M (lanes 5-7) . On the other hand, mutant NC(12-53) was inactive even at a concentration of 2 Â 10 À7 M (lane 8). Interestingly, Tat strongly enhanced ribozyme-directed cleavage of RNA S14 at a concentration of 1-2 Â 10 À8 M (lanes 9-11). The basic Tat peptides (44-61) and (48-86) only slightly enhanced ribozymedirected cleavage of S14 RNA (lanes 15 and 18) , and levels were only a fifth of that with Tat protein at peptide concentration of 1 Â 10 À7 M (see figure 5 legend) . The Tat peptides (1-20) and were inactive even at 1 Â 10 À7 M (lane 12 and data not shown). As expected, RNA template S20 was not cleaved and there was no enhancement of ribozyme cleavage by Tat under these conditions (data not shown; 49).
Tat enhances RNA trans-splicing
To evaluate the role of the Tat chaperoning activity in splicing (21) we used the previously established transsplicing assay (33, 50) , where the pre-mRNA of the thymidylate synthase (td) gene containing a group I 
3′
Step 1 + Tat
Step 2
Step 3 intron was split into two halves. The first RNA transcript, H1, corresponds to the 5 0 exon sequence of 549 nt and 131 nt of the intron while the second RNA transcript, H2, corresponds to the 3 0 part of the intron (147 nt) and part of exon 2 (23 nt) ( Figure 6A ). The two RNAs were 35 S-UMP labelled during transcription and were incubated together. Reactions were started by adding 32 P-GTP, so that the resulting spliced RNA was doubly labelled, internally and at the 5 0 end with 32 P-GTP ( Figure 6A ). In the absence of protein, the reaction was carried out at 558C to allow a productive interaction between H1 and H2 RNAs. Transsplicing was indeed found to take place at 558C but only to a limited extend (data not shown and refs 33,50) but not at 378C according to the accumulation of 32 P-GTP-I1 final product (lane 1 in Figure 6B and C).
HIV-1 NCp7 strongly stimulated trans-splicing (lanes 2-5), with an optimal enhancement at a concentration of Figure 6C ).
DISCUSSION
The Tat protein plays a pivotal role in HIV-1 replication by strongly transactivating proviral DNA transcription, which necessitates the binding of Tat to the 5 0 transactivation response element (TAR) of the nascent viral RNA (9) . This in turn causes the recruitment of the positive elongation factor P-TEFB allowing the rapid synthesis of the full-length HIV-1 mRNA by RNAP II and the cyclic reuse of the viral promoter (16) (17) (18) (19) (51) (52) (53) . The interplay of Tat with the viral RNA extends beyond transcription activation since Tat also influences viral mRNA capping and splicing (20, 21) . In agreement with the view that Tat is multi-functional, it was recently found that Tat can suppress the cellular RNA interference machinery by interacting with DICER, TRBP, siRNA and the mRNA (22, 23) .
A computer analysis of Tat predicts that this small basic protein is essentially unstructured and thus belongs to the growing family of intrinsically unstructured proteins (IUP) (Supplementary Figure 1, ref. 25) . A disordered nature of a protein is thought to render possible interactions with multiple molecular partners (28, 54, 55) , which may account for different functions as in the case of retroviral NC proteins (56) . Intrinsic disorder may also be important for the nucleic acid chaperone activity of Tat, contributing folding energy to nucleic acid rearrangement by way of an entropy exchange mechanism (40).
Interestingly, the majority of proteins involved in transcription regulation was found to contain long disordered regions, indicating that protein chain flexibility is pivotal for this function (57, 58) . To better understand the multiple roles of Tat, we have investigated in vitro its interplay with nucleic acids, notably with DNA, RNA and DNA-RNA hybrid molecules.
Results reported here show that Tat has potent DNA and RNA chaperoning activities as evidenced by its ability to strongly enhance DNA-DNA annealing and exchange (Figures 3 and 4) , ribozyme-directed cleavage of an RNA substrate ( Figure 5 ) and RNA trans-splicing ( Figure 6 ). In agreement with these findings, Tat can activate an RNA-DNA exchange within an RNA-DNA hybrid representing the HIV-1 promoter sequences (Supplementary Figure 2) . Interestingly, Tat has a window of chaperoning activity corresponding to about one protein per 20 to 40 nt (Figures 2-6 ), also found for HIV-1 NC protein with similar values of window of activity (see Figure 5 for example and ref. 46 ). Previously, Guo et al. (59) reported that Tat could replace the HIV-1 NC protein in the initiation of reverse transcription by promoting primer tRNA Lys,3 placement onto the primer binding site and strand transfer in vitro. However, the relevance of these findings is still a matter of speculation, because only very small amounts of Tat are found in virions (60) . Else Tat could well activate the intra-cellular viral DNA synthesis, which occurs in the case of HIV-1 with mutations in the NC zinc finger motifs (61) .
Taken together, these results indicate that Tat is a nucleic acid chaperone with potent nucleic acid annealing and strand-displacement activities, that may act at the levels of proviral DNA transcription, viral RNA splicing and suppression of silencing (Figures 3-6) (8, 9, (21) (22) (23) .
In an attempt to map the Tat sequences responsible for the chaperoning activities, we used peptides representing the N-terminal domain, peptide 1-20, the cysteine-rich domain, peptide 21-43, part of the core and nucleic acidbinding domains, peptide (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) , and the nucleic acidbinding region together with the C-terminal fragment . We also used smaller Tat peptides, namely (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) and (48-61) (see Supplementary Data). Interestingly, the Tat peptide (44-61) was found to be almost as active as the Tat protein in three chaperoning assays (Figures 2, 3, 5 and 6 ). However, the use of a large panel of assays to dissect the chaperoning activities allowed us to find that the Tat peptides (44-61), (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) , (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) and were poorly active in the ribozymedirected cleavage of an RNA substrate ( Figure 5B , Supplementary Figure 3 and Table 3 ). This assay monitors three reactions that are RNA annealing and cleavage, and the release of the end products to allow a cyclic reuse of the R3 ribozyme ( Figure 5A and Materials and methods section). Yet, we do not know what is the limiting step for the Tat peptides (44-61) and in the ribozymedirected cleavage reaction ( Figure 5A ). RNA chaperoning is a complex process, that involves molecular crowding achieved via the formation of nucleoprotein complexes (Figures 2 and 3; refs 46,62) where annealing of complementary strands and eventually their destabilization can take place ( Figure 5 ). The degree of RNA Our results also show that the 18-residue-long peptide is the smallest known peptide with most, but not all, DNA/RNA chaperoning properties (Table 3 ). The use of such a small peptide should facilitate highthroughput screening aimed at identifying small molecules capable of inhibiting Tat and thus HIV-1 proviral DNA transcription and viral RNA splicing. This is presently in progress. 
